Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic)

Indian Journal of Cancer

Volumn 48, Issue 1, 2011, Pages 18-23

  Uthappa, M C ^a   Ravikumar, R ^b   Gupta, A ^c  

^a MANIPAL HOSPITAL   (India)

^b Thambiran Hospital   (India)

^c SIR GANGA RAM HOSPITAL   (India)

Author keywords

quality of life; targeted therapy; Unresectable

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ANGIOSARCOMA; ANOREXIA; BILE DUCT CARCINOMA; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOID; CHOROID MELANOMA; COLON CANCER; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; DOSIMETRY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FATIGUE; FEVER; GALLBLADDER CANCER; GASTROINTESTINAL STROMAL TUMOR; HEPATITIS; HUMAN; KIDNEY CANCER; LETHARGY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG CANCER; LUNG INJURY; MOUTH CANCER; NAUSEA; NEUROENDOCRINE TUMOR; OVARY CANCER; PANCREAS CANCER; PANCREATITIS; PANCYTOPENIA; PROSTATE CANCER; RADIATION PNEUMONIA; SARCOMA; SELECTIVE INTERNAL RADIATION THERAPY; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STOMACH ULCER; THYMUS CANCER; THYROID CANCER; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UPPER ABDOMINAL PAIN; UTERINE CERVIX CANCER; UVEA MELANOMA;

BRACHYTHERAPY; CLINICAL TRIALS AS TOPIC; HUMANS; LIVER NEOPLASMS; MICROSPHERES; PROGNOSIS; YTTRIUM RADIOISOTOPES;

EID: 79951984356     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.76625     Document Type: Conference Paper

References (36)

1. Colorectal Cancer General Information - About Colorectal Cancer. Available from: http://www.cancerfacts.com/GeneralContent/Colorectal/Gen- ColorectalCancerIncidence.asp?CB=6. [accessed on 2010 Jul 29].
2. A free online surgical resource. Available from: http://www.surgical- tutor.org.uk/default-home.htm?system/abdomen/liver-mets.htm~right. [accessed on 2010 Jul 29].
3. Cole, DJ, Ferguson, CM. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg 1992;58:88-91.
4. Murthy R, Habbu A, Salem R. Trans-arterial hepatic radioembolisation of yttrium-90 microspheres. Biomed Imaging Interv J 2006;2:e43. Available from: http://www.biij.org/2006/3/e43/.
5. Wang SC, Bester L, Burnes JP, Clouston JE, Hugh TJ, Little AF, et al. Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer. J Med Imaging Radiat Oncol 2010;50:178-87.
6. What are SIR-Spheres Microspheres? Available from: http://www.sirtex.com/ content.cfm?sec=worldandMenuID=A040E9B4. [accessed on 2010 Jul 29].
7. Summary of Safety and Effectiveness and labeling Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num= p990065. [accessed on 2010 Jul 29].
8. Zacharoulis D, Habib NA, Jiao R. The use of Sirtex in inoperable liver tumours: A surgeon's view. In Karaliotas C, Broelsch C, Habib N, editors. New York: Liver and Biliary Tract Surgery. Springer; 2006. p. 419-20.
9. Theraspheres. http://en.wikipedia.org/wiki/TheraSphere. [accessed 27th Nov 2010].
10. Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of (90)Y microspheres in man: Review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004;60:1552-63.
11. Wasan HS. The role of radioembolisation using SIR-spheres in secondary liver metastases of non-colorectal cancer origin - emerging clinical data. Eur Oncol 2008;4:70-4.
12. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium (REBOC). Int J Radiat Oncol Biol Phys 2007;68:13-23. (Pubitemid 46589861)
13. Salem R. Radioembolization with 90Y microspheres: Technical considerations. J Vasc Interv Radiol 2007;18:1460-1. (Pubitemid 350001257)
14. Jakobs TF, Hoffmann RT, Tatsch K, Trumm C, Reiser MF, Helmberger TK. Developments and perspectives in radioablative techniques. Radiologe 2007;47:1083-8. (Pubitemid 350231418)
15. Hoffmann RT, Jakobs TF, Reiser MF. Identification of candidates and selection criteria. In: Bilbao JI, Reiser MD, editors. Liver radioembolization with 90Y microspheres. Berlin: Springer-Verlag; 2008. p. 11-4.
16. van Hazel GA, Pavlakis N, Goldstein D, Olver IN, Tapner MJ, Price D, et al. Treatment of 5FU refractory patients with liver metastasis from colorectal cancer by using 90Y resin microsphere plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 2008;20:8116.
17. Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Physics Med Biol 2001;46:487-98. (Pubitemid 32148511)
18. Gulec SA, Siegel JA. Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres. J Nucl Med 2007;48:2080-6. (Pubitemid 350232320)
19. Dezarn WA. Quality assurance issues for therapeutic application of radioactive microspheres. Int J Radiat Oncol Biol Phys 2008;71:s147-51.
20. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, et al. Radioembolization with 90Y microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol 2007;30:571-92. (Pubitemid 350092259)
21. Salem R, Thurston K. Radioembolization with 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 3: Comprehensive literature review and future direction. J Vasc Interv Radiol 2006;17:1571-94.
22. Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008;19:1187-95.
23. Wong C, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM, et al. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F] Fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interven Radiol 2005;16:1101-6. (Pubitemid 41177123)
24. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001;12:1711-20. (Pubitemid 34105661)
25. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004;88:78-85. (Pubitemid 39536508)
26. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, et al. Comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009;9:1920-8.
27. Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007;25:1099-106. (Pubitemid 46596762)
28. Sharma RA, Wasan HS, Love SB, Dutton S, Stokes JC, Smith JL. FOXFIRE: A phase III clinical trial of chemo-radio-embolisation as first-line treatment of liver metastases in patients with colorectal cancer. Clin Oncol (R Coll Radiol) 2008;20:261-3.
29. Lau WY, Leung WT, Ho S, Leung NW, Chan M, Lin J, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase I and II study. Br J Cancer 1994;70:994-9. (Pubitemid 24331102)
30. Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998;40:583-92. (Pubitemid 28104228)
31. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 2004;240:299-305. (Pubitemid 38963022)
32. Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS. Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 2006;10:413-6. (Pubitemid 43303837)
33. Liapi E, Geschwind JF. Intra-arterial therapies for hepatocellular carcinoma: Where do we stand? Ann Surg Oncol 2010;17:1234-46.
34. Nutting CK, Kennedy A, Coldwell D, Jones B, Quarnberg D. Coil embolization prevents GI ulcers during Yttrium-90 hepatic radioembolization. J Vasc Interv Radiol 2004;15:Supp.
35. Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995;33:919-24.
36. Mantravadi RV, Spigos DG, Tan WS, Felix EL. Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 1982;142:783-6. (Pubitemid 12180973)